Do telomere peptides fuel cancer?
6:18–6:59 · 41s
Nathalie weighs Cavenson’s literature showing mortality reductions against the lack of clarity in active cancer, landing on a firm caution against bioregulators during active disease.
6:18–6:59 · 41s
Nathalie weighs Cavenson’s literature showing mortality reductions against the lack of clarity in active cancer, landing on a firm caution against bioregulators during active disease.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.